Skip to main content

Loss of libido

Medical Professionals

Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.

Continue reading below

What is loss of libido?1

Libido is conscious or unconscious sexual desire. Loss of libido is a sexual dysfunction relating to loss of sexual desire or sexual drive and is also termed hypoactive sexual desire disorder (HSDD). HSDD is characterised by:

  • A deficiency of sexual thoughts, feelings, or receptiveness to sexual stimulation,

  • That has been present for at least six months,

  • Causes personal distress, and

  • Is not due to another medical condition.

Loss of libido must not be confused with other sexual dysfunctions as these can impair libido. Erectile Dysfunction is dealt with in a separate article.

How common is loss of libido? (Epidemiology)

  • It is a common problem but it is difficult to quantify because definitions may vary and few of those who experience loss of libido consult a doctor even when it may be the cause of relationship difficulties.

  • Studies of the prevalence in men have produced extremely variable results, and are particularly affected by under-reporting and not seeking help.

  • Nearly half of women in the USA report problems with sexual function. Many healthcare providers do not ask about sexual concerns during routine clinical encounters because of their own personal discomfort, lack of familiarity with treatment, or the belief that they lack adequate time to address this complex issue.1

  • Hypoactive sexual desire disorder affects approximately 10% of adult women.2

A review of articles revealed some interesting points:

  • In Hong Kong a telephone survey showed a high prevalence of sexual problems generally and in women a 25% prevalence of loss of interest in sex. Sex-related knowledge, perceived importance of sex, perceived physical health status and sexual satisfaction were predictors of sexual problems.3

  • Gender differences and strong cultural influences were apparent. Moreover, sexual problems and sexual satisfaction were associated with mental health, quality of life indicators and overall life satisfaction.3 4

  • It is normal for sexual drive to diminish with the passage of years but the degree is highly variable.5 This effect is significantly more marked in women than in men.6 Diminished sexual potency and vaginal dryness may contribute to reduced libido.

  • It also seems that qualitative aspects of sexual activity may change and improve with age.7 It would be a mistake to link libido with either 'performance' or sexual satisfaction.

Continue reading below

Loss of libido symptoms

It is fairly uncommon for a patient to present directly with a complaint of loss of libido. It is more likely to be a component of other complaints. Many people are still reluctant to discuss such matters and feel embarrassed. It is often introduced into the consultation by patients as an apparent afterthought. The following are likely to need consideration:

  • What does the patient mean by loss of sexual drive? Is it loss of the will or loss of the way?

  • Is there a problem with performance? If so, which came first?

  • How long ago did it start? Was it gradual or sudden? Has it been progressive?

  • How is the relationship? If it is problematical, which came first?

  • Has there been criticism from the partner or even a sympathetic discussion?

  • How does the patient feel about the loss of libido? Perhaps the patient feels that it is not really a problem, except for the demands of the partner.

  • What sexual difficulties have been experienced (including erectile dysfunction or dyspareunia)?

  • Whose idea was the consultation? Is the patient here willingly or under duress?

  • Are there any other problems of health? Are there any chronic diseases? What medication is taken? Has there been any recent change?

  • What is their alcohol intake?

  • If a woman of appropriate age, ask about symptoms of the climacteric.

  • If appropriate, ask about contraception. There may be fear of pregnancy.

  • Ask about mental health too. Screening for depression in general practice can be performed with just two questions:

    • During the last month, have you often been bothered by feeling down, depressed or hopeless?

    • During the last month, have you often been bothered by having little interest or pleasure in doing things?

  • Ask about work. Are there pressures there? Are there financial problems or family difficulties?

  • Ask what may be the most revealing question of them all. 'What do you think is the reason for your loss of sexual drive?'

  • Difficulties with sexuality may lead to problems with libido.

Differential diagnosis

  • Any form of mental illness is likely to be associated with loss of libido. The most common of these is depression. Other features of depression may be clear, or a tool such as the Hospital Anxiety and Depression (HAD) Scale may be needed to test the diagnosis or to convince the patient.8

  • Libido is associated with well-being. Hence, illness will depress libido. Loss of libido is very common during cancer treatment.

  • Overwork, chronic tiredness and anxiety can all depress libido.

  • Falling levels of hormones may impair libido. This can occur in the climacteric or with the treatment of prostate cancer.

  • Some drugs may induce loss of libido, perhaps through an element of depression. Antihypertensives are the most notorious.

  • Loss of libido after having a baby is not uncommon. Hormonal fluctuation can be a problem. There may have been vaginal trauma and there may still be some tenderness. There may have been a change in self-image. Mothers with small babies are often very tired and may be frequently disturbed at night.

  • Chronic high intake of alcohol depresses sexual desire and cirrhosis can depress androgen levels.

  • If sex is not fulfilling then interest will wane. There may be erectile dysfunction, premature ejaculation, failure of ejaculation or performance anxiety due to criticism.

  • Dyspareunia, often due to vaginal dryness or even susceptibility to recurrent cystitis, may take the pleasure from sex and hence the drive.

  • Libido will suffer if there are problems within a relationship. Sex may be less attractive to one who thinks that the partner is having an affair.

  • Sex may have become ritualistic and mundane. There may be differences in ambition and imagination between partners when considering how to enliven their sex life.

Continue reading below


Examination is likely to be unrewarding unless there are specific indicators from the history. However, it may be reassuring to the patient to show that the doctor is taking the issue seriously and there is no physical abnormality.


If the diagnosis is already clear then further investigations are not required.

  • A tool such as the HADS may be useful.

  • FBC is a good, general screening test. A raised MCV may point to excessive alcohol consumption.

  • U&E will check for renal disease and Na and K may be deranged in adrenal disease.

  • LFTs may also suggest excessive intake of alcohol, especially if gamma GT is raised.

  • TFTs may demonstrate hypothyroidism.

  • Follicle-stimulating hormone (FSH), luteinising hormone (LH), prolactin and either estradiol or testosterone may indicate hormonal inadequacy. This may be due to drugs or alcohol.

  • If erectile dysfunction appears to be a problem,and poor performance may have led to loss of interest then fasting glucose and cholesterol are in order, as there is a strong link between erectile dysfunction and both diabetes and coronary heart disease.

Associated diseases

  • Probably the most frequent co-existent disease to discover is depression.

  • Hormone inadequacy, including hypothyroidism, is less common.

  • Problems with relationships are common.

Treatment and management of loss of libido

Management depends on the individual underlying causes of loss of libido. Treatments may include:

  • If there seems to be an underlying problem of a psychosexual nature or problems with the relationship then counselling may be required. An agency such as Relate, may be very valuable. See separate article Sex Therapy and Counselling.

  • If the problem is overwork, financial worries and associated anxiety, lifestyle needs to be considered. The relationship between work and the rest of life needs to be examined by the patient and spouse. If there is worry over financial matters these may need appropriate professional help and advice.

  • Depression may need treatment. Some antidepressants have been associated with loss of libido but it may be difficult to know if the cause is the drug or the underlying depression.

  • Antipsychotics such as phenothiazines and haloperidol raise prolactin. Raised prolactin is associated with dampened sexual arousal.

  • Counselling may be required with regard to alcohol use.

  • If hypotensive treatment is thought to be a problem, a change in the type of medication may be tried.

  • If hypothyroidism has been diagnosed then thyroxine is started to suppress the level of TSH.

  • Oestrogen appears to bring some benefit in menopausal women but its specific effects on libido as opposed to the other sexual functions during the menopausal phase require further research.9

  • The National Institute for Health and Care Excellence (NICE) recommends that testosterone supplementation should be considered for menopausal women with low sexual desire if HRT alone is not effective.10

  • The literature supporting the use of testosterone for the treatment of HSDD in men is equivocal. Some studies support benefit whilst others do not. This variability may well be due to the interaction between exogenous testosterone and the homeostatic mechanism governing the level of its naturally occurring counterpart.11

  • The aim of testosterone replacement therapy for hypoandrogenic states is to improve symptoms and signs of testosterone deficiency, including decreased libido, erectile dysfunction, depressed mood, anaemia, and loss of muscle and bone mass, by increasing serum testosterone levels to the physiological range.12

  • Medication (such as sildenafil) may be valuable if there is erectile dysfunction.

Hormones and libido

The suggestion that the cause of impaired libido is a deficiency of hormones is usually overly simplistic. It is likely that there is an interplay between hormonal, neurobiological and psychosocial factors. In general, dopamine, oestrogen, progesterone and testosterone play an excitatory role in sexual desire, whereas serotonin and prolactin have an inhibitory effect.13

The changes in reproductive capacity and their relationship with reproductive behaviour are complex.14 15

A Cochrane review did not find evidence to support the use of either tibolone or selective oestrogen receptor modulators (eg, raloxifene) in the treatment of low libido in perimenopausal or postmenopausal women.16

Another Cochrane review found that dehydroepiandrosterone may slightly improve sexual function in perimenopausal and postmenopausal women but are associated with significant androgenic effects.17

Further reading and references

  • Cunningham GR, Stephens-Shields AJ, Rosen RC, et al; Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials. J Clin Endocrinol Metab. 2015 Mar;100(3):1146-55. doi: 10.1210/jc.2014-3818. Epub 2014 Dec 30.
  1. Pettigrew JA, Novick AM; Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment. J Midwifery Womens Health. 2021 Nov;66(6):740-748. doi: 10.1111/jmwh.13283. Epub 2021 Sep 12.
  2. Goldstein I, Kim NN, Clayton AH, et al; Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review. Mayo Clin Proc. 2017 Jan;92(1):114-128. doi: 10.1016/j.mayocp.2016.09.018. Epub 2016 Dec 1.
  3. Lau JT, Kim JH, Tsui HY; Prevalence of male and female sexual problems, perceptions related to sex and association with quality of life in a Chinese population: a population-based study. Int J Impot Res. 2005 Nov-Dec;17(6):494-505.
  4. Lau JT, Kim JH, Tsui HY; Prevalence and factors of sexual problems in Chinese males and females having sex with the same-sex partner in Hong Kong: a population-based study. Int J Impot Res. 2006 Mar-Apr;18(2):130-40.
  5. Araujo AB, Mohr BA, McKinlay JB; Changes in sexual function in middle-aged and older men: longitudinal data from the Massachusetts Male Aging Study. J Am Geriatr Soc. 2004 Sep;52(9):1502-9.
  6. Kalra G, Subramanyam A, Pinto C; Sexuality: desire, activity and intimacy in the elderly. Indian J Psychiatry. 2011 Oct;53(4):300-6. doi: 10.4103/0019-5545.91902.
  7. Hurd Clarke L; Older women and sexuality: experiences in marital relationships across the life course. Can J Aging. 2006 Summer;25(2):129-40.
  8. Hospital Anxiety and Depression Scale (HADS); GL Assessments
  9. Nappi RE, Martini E, Terreno E, et al; Management of hypoactive sexual desire disorder in women: current and emerging therapies. Int J Womens Health. 2010 Aug 9;2:167-75.
  10. Menopause: diagnosis and management; NICE Guideline (November 2015 - last updated December 2019)
  11. Montgomery KA; Sexual desire disorders. Psychiatry (Edgmont). 2008 Jun;5(6):50-5.
  12. Barbonetti A, D'Andrea S, Francavilla S; Testosterone replacement therapy. Andrology. 2020 Nov;8(6):1551-1566. doi: 10.1111/andr.12774. Epub 2020 Mar 9.
  13. Clayton AH; The pathophysiology of hypoactive sexual desire disorder in women. Int J Gynaecol Obstet. 2010 Jul;110(1):7-11. doi: 10.1016/j.ijgo.2010.02.014.
  14. Randolph Jr JF; The Endocrinology of the Reproductive Years. J Sex Med. 2008 Jul 1.
  15. Andersson H, Rehm S, Stanislaus D, et al; Scientific and regulatory policy committee (SRPC) paper: assessment of circulating hormones in nonclinical toxicity studies III. female reproductive hormones. Toxicol Pathol. 2013 Aug;41(6):921-34. doi: 10.1177/0192623312466959. Epub 2013 Jan 18.
  16. Nastri CO, Lara LA, Ferriani RA, et al; Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2013 Jun 5;6:CD009672. doi: 10.1002/14651858.CD009672.pub2.
  17. Scheffers CS, Armstrong S, Cantineau AE, et al; Dehydroepiandrosterone for women in the peri- or postmenopausal phase. Cochrane Database Syst Rev. 2015 Jan 22;1:CD011066. doi: 10.1002/14651858.CD011066.pub2.

Article history

The information on this page is written and peer reviewed by qualified clinicians.

symptom checker

Feeling unwell?

Assess your symptoms online for free